Dr Bozza’s research team activities involve clinical and translational research on severe emerging and re-emerging infectious diseases, the quality and effectiveness of critical care, antimicrobial resistance, and the long-term consequences of critical illness.

The investigations have focused on the long-term outcomes of severe infections, including the neuro-cognitive consequences of sepsis, malaria, and HIV. In recent years, he also worked in the consolidation of new collaborative initiatives of clinical research in Brazil and Latin America to fill the gaps of knowledge regarding the management of critically ill patients in developing countries and the development of large collaborative studies in these settings.

His group has also made significant contributions to managing emerging infectious diseases, including studies on dengue, Zika, CHIKV, yellow fever, and COVID-19. Dr Bozza is member of the board of directors and representative for the South America at the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC). During the COVID-19 pandemic, Dr Bozza’s group worked on several questions, including the impact of the pandemic in the Brazilian health system, inequity in health care, the evolution of mortality nationwide data, and the vaccination rule out campaign in Brazil.